AKT1 and chronic obstructive pulmonary disease: A growing body of research has demonstrated the involvement of the PI3K/Akt/mTOR signaling pathway in promoting lung cell senescence and oxidative stress (Xiaofe et al., 2022), This suggests that blocking the PI3K/Akt pathway as a means to inhibit oxidative stress could hold promise as a therapeutic strategy for COPD patients.